Why Is Inspire (INSP) Down 4.1% Since Last Earnings Report?
Inspire Medical Systems (INSP) reported Q2 2026 earnings that beat estimates with adjusted EPS of 14 cents versus expected loss of 22 cents, and raised full-year 2026 guidance. However, U.S. revenues declined 9.6% year-over-year due to coding and reimbursement challenges, partially offset by strong 33.6% international revenue growth. The stock has declined 4.1% since earnings despite the Zacks Rank #1 (Strong Buy) rating.